Companies
National Companies
VIRALGEN VECTOR CORE
- Technical and regulatory advice for the construction and validation of a facility for the manufacturing of AAV viral vectors therapy.
- Specialized training in GMP for Advanced Therapy Medicinal Products (ATMPs).
- GMP audit for the manufacturing of AAV viral vectors therapy.
- Preparation of CMC for the presentation of the application for an IND for a gene therapy medicine.
SYNGOI
- Advising and collaboration with Engineering in the design of a new manufacturing facility in Derio, Vizcaya.
- Initial Scientific Advice for the new facilities for the Inspection and Control Department of AEMPS.
TYRIS
- Technical advice for the classification of a Gene Therapy Medicine at EMA (European Medical Agency).
CLINICA DKF
- Advising on the Development of Strategies and the use of Advanced Therapy Medicinal Products (ATMPs) for Regenerative Medicine.
IMERETI
- Specialized training in the Development of Advanced Therapy Medicinal Products (ATMPs).
MR2LAB (XCELL Medical Solutions)
- Scientific advice on AEMPS for the classification, design and development of a Cell Therapy product.
- Advising on the Development and Marketing of Advanced Therapy.
HISTOCELL
- Technical advice on the adaptation and expansion of facilities with classified areas.
- GMP audit of the facilities/Cell Therapy Medicine manufacturing.
PRAXIS BIOPHARMACEUTICALS
- GMP audits for the manufacturing of Cell Therapy medicines.
- Feasibility plan for the manufacturing of Gene Therapy medicines.
- Support in the preparation of specifications and validation of suppliers.
EQUICORD
- Implementation of GMP regulations for Cell Therapy for veterinary use.
- GMP certificate issued by AEMPS.
- Technology transfer to a third-party manufacturer (CMO). Technical and regulatory advice for the development of an Advanced Therapy Medicinal Product (ATMP) for veterinary use. Creation of internal documentation in compliance with GMP regulations.
VIVEBIOTECH
- Implementation of GMP regulations for the manufacturing of viral vectors for use in Advanced Therapy Medicinal Products (ATMPs).
- GMP certificate issued by AEMPS.
- Technology transfer and Technical and Regulatory Advice for the development of a Gene Therapy medicine.
TIGENIX, SAU
- Regulatory and Quality support.
- Management of the Company’s corporate Quality System.
- GMP audits for the manufacturing of Cell Therapy medicines.
CORETHERAPIX, SLU
- Management and Maintenance of the Quality System. Support in logistics and medication management in the CAREMI Clinical Trial.
- Management and technical advice for the Technology Transfer of the manufacturing process of cardiac stem cells to a CMO.
- Training in Quality issues.
GENETRIX /SILO
- Regulatory advice, project evaluation and technology transfer of Advanced Therapies and Innovative Products.
SPHERUM BIOMED, SL
- Technical and documentary advice for the development of a viral vector manufacturing platform.
BIODAN
- Regulatory advice for the development of Tissue Engineering Medicines.
CITOSPIN
- Project to scale up the manufacturing process of a cell therapy medicine for allogeneic use.
- Regulatory advice: scientific advice on AEMPS.
CLINICA DIAGONAL
- Preparation and presentation of the CTD for the authorization of use of an advanced therapy medicinal product (ATMP) of non-industrial manufacturing.
- Regulatory advice: scientific advice on AEMPS.
CLINICA CEMTRO
- Technical and regulatory advice for the scaling of the manufacturing of allogeneic chondrocytes.
- Scientific advice on AEMPS.
TECBIOCEL
- Scientific advice on AEMPS for the development of pre-clinical ATMP for COVID-19.
- Scientific advice on AEMPS for the design and development of a Cell Therapy Medicine.
- Authorization and GMP certificate issued by AEMPS.
CLÍNICA DERMATOLÓGICA ERCILLA, SLU
- Technical and regulatory advice for the development of an alopecia treatment using stem cells and growth factors.
PROPOSIT SL
- Collaboration project for the technology transfer and marketing of a method for obtaining PRP.
- Audit in compliance with the Regulations of Use of Platelet Rich Plasma.
REGENIA, SL
- Technical and documentary advice for the certification of a pharmaceutical laboratory for the manufacturing of growth factors derived from platelet-rich blood plasma.
BIOHOPE
- Design of Quality System for R&D activities.
BIC GUIPUZKOA
- Preparation and review of documentation related to biosafety and work standards in the facilities of the bio-incubator of companies.
CELLUS BIOMEDICA
- Strategic advice for the Cellus project in Spain: planning and Project Evaluation.
POLIMERBIO
- Business plan for a medical polymers manufacturing company.
ALGENEX
- GMP Diagnosis Audit for the manufacturing of an insect-based biotech product.
- Technical advice on the facility design for the production of an insect-based biotech product.
MIKROBIOMIK
- Scientific advice on AEMPS for the development of a gut microbiota product.
QUATRE S.L.
- GMP and technical training. Advising on the implementation of the GMP Quality System.
International Companies
SEVIBE
Poland—
- GMP audit of facilities/manufacturing in the Polish Stem Cell Bank.
BEBEVIDA
Portugal—
- GMP audit of the facilities of the Cord Blood Bank (Oporto).
STEMMATTERS
Portugal—
- GLP audit of the pre-clinical CRO responsible for non-clinical safety studies.
CELLS FOR CELLS
Chile—
- Specialized training in the Development of Advanced Therapy Medicinal Products (ATMPs).
LABORATORIOS LEGRAND
Bogotá, Colombia—
- Audit of facilities, processes and Quality Management System (QMS) of the Keraderm Laboratory in Bogota.
IPS – UNIVERSIDAD DE ANTIOQUIA
Medellin, Colombia—
- Audit of facilities, processes and Quality Management System (QMS) of the Cell Therapy Laboratory and Biobank of IPS-Universidad Antioquia.
CELLAB
Andorra—
- Technical advice on the adaptation and expansion of facilities with classified areas. Feasibility study.
- Implementation of GMP regulations for the manufacturing of ATMP. Strategy consulting for the development and marketing of medicines.
VISCOFAN NATURIN, GmbH
Germany —
- Preparation of an IMPD for a clinical trial.
- Technical and regulatory advice for the development and marketing of a Cell Therapy Medicine. Technology Transfer to a third-party manufacturer (CMO).
MEDXCELL
Switzerland—
- Scientific advice on the Swiss Medicine Agency, Swissmedic: advice on the design of the clinical trial, and pre-clinical and clinical studies.
- Evaluation, selection and validation of a CDMO for the manufacturing of a Cell Therapy Medicine based on mesenchymal cells.
CELLUS BIOMEDICA
Chile—
- Strategic advice for the Cellus project in Spain: planning and project evaluation.